Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women
Clinical trial NCT05457894 · COMPLETED
Trial details
- NCT number
- NCT05457894
- Sponsor
- St. Petersburg Research Institute of Vaccines and Sera
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-23
- Primary completion
- 2021-03-11
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.